Framingham, MA, United States of America

Nicholas Kushner


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicholas Kushner: Innovator in Cell-Mediated Immune Response

Introduction

Nicholas Kushner is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of immunology, particularly in methods that enhance cell-mediated immune responses. His innovative approach has the potential to impact vaccine development and therapeutic strategies.

Latest Patents

Nicholas Kushner holds a patent titled "Methods and compositions for promoting a cell-mediated immune response." This invention focuses on a method for stimulating a cell-mediated immune response to an antigen by administering a target antigen alongside a transport factor derived from a bipartite protein exotoxin. The transport factor is designed to enhance the immune response without the corresponding protective antigen. This patent represents a significant advancement in the field of immunology, with applications for various viral and tumor antigens.

Career Highlights

Kushner is associated with Vaccine Technologies, Incorporated, where he applies his expertise in immunology to develop innovative solutions. His work is characterized by a commitment to advancing the understanding of immune responses and improving vaccine efficacy. With a patent portfolio that includes one patent, he continues to contribute to the scientific community.

Collaborations

Nicholas Kushner collaborates with talented individuals such as Yichen Lu and Amie Strong. These partnerships enhance the research and development efforts at Vaccine Technologies, Incorporated, fostering an environment of innovation and discovery.

Conclusion

Nicholas Kushner is a prominent inventor whose work in promoting cell-mediated immune responses is paving the way for advancements in immunology. His contributions are vital to the ongoing development of effective vaccines and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…